Clodronate, a drug used to treat hypercalcemia, has demonstrated inhibitory capacity on the activity of MMP-1, MMP-3, MMP-8, and MMP-9 by acting as a cation-chelator [61,62]. Here, MMP9 is linked to hypercalcemia disease.